| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Prostacyclin receptor |
|---|
| Ligand | BDBM50101827 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_158461 |
|---|
| Ki | >10000±n/a nM |
|---|
| Citation |  Tani, K; Naganawa, A; Ishida, A; Egashira, H; Sagawa, K; Harada, H; Ogawa, M; Maruyama, T; Ohuchida, S; Nakai, H; Kondo, K; Toda, M Design and synthesis of a highly selective EP2-receptor agonist. Bioorg Med Chem Lett11:2025-8 (2001) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Prostacyclin receptor |
|---|
| Name: | Prostacyclin receptor |
|---|
| Synonyms: | PGI receptor | PI2R_HUMAN | PRIPR | PTGIR | Prostacyclin (IP) Receptor | Prostacyclin receptor | Prostaglandin I | Prostaglandin I2 | Prostaglandin I2 receptor | Prostanoid IP receptor |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 40968.22 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | The membranes prepared from human platelet were used in binding assay. |
|---|
| Residue: | 386 |
|---|
| Sequence: | MADSCRNLTYVRGSVGPATSTLMFVAGVVGNGLALGILSARRPARPSAFAVLVTGLAATD
LLGTSFLSPAVFVAYARNSSLLGLARGGPALCDAFAFAMTFFGLASMLILFAMAVERCLA
LSHPYLYAQLDGPRCARLALPAIYAFCVLFCALPLLGLGQHQQYCPGSWCFLRMRWAQPG
GAAFSLAYAGLVALLVAAIFLCNGSVTLSLCRMYRQQKRHQGSLGPRPRTGEDEVDHLIL
LALMTVVMAVCSLPLTIRCFTQAVAPDSSSEMGDLLAFRFYAFNPILDPWVFILFRKAVF
QRLKLWVCCLCLGPAHGDSQTPLSQLASGRRDPRAPSAPVGKEGSCVPLSAWGEGQVEPL
PPTQQSSGSAVGTSSKAEASVACSLC
|
|
|
|---|
| BDBM50101827 |
|---|
| n/a |
|---|
| Name | BDBM50101827 |
|---|
| Synonyms: | (Z)-7-{(1R,2R,3R)-2-[(E)-(S)-4-(1-Ethyl-cyclobutyl)-4-hydroxy-but-1-enyl]-3-hydroxy-5-oxo-cyclopentyl}-hept-5-enoic acid | CHEMBL64483 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H34O5 |
|---|
| Mol. Mass. | 378.5024 |
|---|
| SMILES | CCC1(CCC1)[C@@H](O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O |
|---|
| Structure | 
|
|---|
Search and Browse
